Second global meeting on skin NTDs focuses on advancing integration and innovation
WHO partners with Thailand and Sri Lanka to pilot a new tool to combat and address infodemics
WHO announces the development of updated guidance on HIV service delivery
WHO calls for urgent action to address worldwide disruptions in tuberculosis services putting millions of lives at risk
Crimean-Congo haemorrhagic fever in Iraq: a risk communication and community engagement success story
WHO prequalifies first maternal respiratory syncytial virus vaccine
New Health Investment Platform to improve primary health care convenes its first Steering Committee
WHO Director-General and Civil Society Task Force on TB release joint statement on sustaining the momentum to end TB
Third meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024
Nearly 50 million people sign up call for clean air action for better health
The multi-partner Access and Allocation Mechanism allocates 238 000 doses of mpox vaccine to four countries
UN Commission approves WHO recommendations to place psychoactive substances under international control
Medical Product Alert N°1/2025: Falsified (contaminated) OXYCONTIN 80mg
Frank, in-depth discussion as Belgium and WHO map ahead priorities for collaboration
Member States support polio transition progress at 156th Executive Board
World Health Day 2025: explore free courses to enhance maternal and newborn health
Many pregnancy-related complications going undetected and untreated – WHO
WHO and Switzerland cement cooperation until 2028
Strengthening public health across Lebanon with EIB Global
Building a healthier world by women and for women is key to achieving gender equality
New study highlights the potential impact of funding cuts on the HIV response
United Nations Decade of Action on Nutrition (2016–2025) extended to 2030
New WHO guidance calls for urgent transformation of mental health policies
Types of data requested to inform May 2025 COVID-19 vaccine antigen composition deliberations
Despite global influenza vaccine production remaining steady, production and distribution challenges remain
Influenza surveillance in conflict-affected areas of Myanmar
Enhancing respiratory syncytial virus (RSV) surveillance in Mongolia
Expanding the Global Influenza Surveillance and Response System to include other respiratory viruses with epidemic or pandemic potential
Harnessing innovation and fostering responsible use of life sciences
